HLA
NGM

Hamilton Lane Advisors’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Hamilton Lane Advisors’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-37,503
Closed -$481K – 77
2022
Q2 		$481K Buy
+37,503
New +$481K 0.19% 43
2021
Q4 		– Sell
-62,500
Closed -$1.31M – 107
2021
Q3 		$1.31M Buy
+62,500
New +$1.31M 0.22% 42